cucurbitacins has been researched along with Neoplasms in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 4 (44.44) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, D; Capinpin, SM; Chauhan, A; Dhama, K; Kumar, AP; Kumar, M; Lee, EHC; Ramniwas, S; Ranjan, A; Rath, P; Sak, K; Tuli, HS; Yap, KC | 1 |
Haque, S; Kaur, S; Kumar, A; Parashar, G; Parashar, NC; Ramniwas, S; Rani, I; Sharma, B; Sharma, U; Tuli, HS | 1 |
Gao, C; Li, H; Li, Y; Sun, C; Yao, Y; Zhuang, J | 1 |
Farooqi, AA; Lin, X | 1 |
Ali, M; Green, IR; Hussain, H; Irshad, M; Khattak, KF; Saleem, M | 1 |
Arumuggam, N; Bhowmick, NA; Rupasinghe, HP | 1 |
Cai, Y; Chen, M; Fang, X; He, C; Li, P; Wang, Y; Xiao, F | 1 |
Iwanski, GB; Lee, DH; Thoennissen, NH | 1 |
Bao, J; Chen, X; Ding, Q; Guo, J; Huang, M; Lu, J; Wang, Y | 1 |
9 review(s) available for cucurbitacins and Neoplasms
Article | Year |
---|---|
Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends.
Topics: Antineoplastic Agents; Apoptosis; Cucurbitacins; Humans; Neoplasms; Signal Transduction; Triterpenes | 2022 |
Apoptotic and antimetastatic effect of cucurbitacins in cancer: recent trends and advancement.
Topics: Apoptosis; Cell Proliferation; Cucurbitacins; Humans; Neoplasms; Phosphatidylinositol 3-Kinases; Triterpenes | 2023 |
Potential of cucurbitacin as an anticancer drug.
Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Proliferation; Cucurbitacins; Humans; Neoplasms; Triterpenes | 2023 |
Cucurbitacin mediated regulation of deregulated oncogenic signaling cascades and non-coding RNAs in different cancers: Spotlight on JAK/STAT, Wnt/β-catenin, mTOR, TRAIL-mediated pathways.
Topics: Animals; Cucurbitacins; Humans; Janus Kinases; Neoplasms; Phytochemicals; RNA, Untranslated; Signal Transduction; STAT Transcription Factors; TNF-Related Apoptosis-Inducing Ligand; TOR Serine-Threonine Kinases; Wnt Signaling Pathway | 2021 |
Cucurbitacins as Anticancer Agents: A Patent Review.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cucurbitacins; Drug Design; Humans; Neoplasms; Patents as Topic; Structure-Activity Relationship; Triterpenes | 2019 |
A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer.
Topics: Animals; Catechin; Cell Proliferation; Cucurbitacins; Curcumin; Disease Models, Animal; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Janus Kinases; Neoplasms; Phytochemicals; Resveratrol; Signal Transduction; STAT Transcription Factors; Stilbenes | 2015 |
Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Cucurbitacins; Docetaxel; Drug Therapy, Combination; Humans; Methotrexate; Molecular Conformation; Neoplasm Invasiveness; Neoplasms; Phytotherapy; Signal Transduction; Structure-Activity Relationship; Taxoids | 2015 |
Cucurbitacin: ancient compound shedding new light on cancer treatment.
Topics: Antineoplastic Agents; Cucurbitacins; Drug Screening Assays, Antitumor; Humans; MAP Kinase Signaling System; Neoplasms; Transcription Factors | 2010 |
Biological activities and potential molecular targets of cucurbitacins: a focus on cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cucurbitacins; Drug Design; Humans; Molecular Targeted Therapy; Neoplasms | 2012 |